Isoket

Isoket

Dosage
10mg
Package
360 pill 180 pill 120 pill 90 pill 60 pill 30 pill
Total price: 0.0
  • In many pharmacies and online e‑pharmacies isoket (isosorbide dinitrate) can be purchased without a prescription and delivered to the United Kingdom; however, in regulated markets it is officially classified as prescription‑only (Rx), so availability without a receipt may vary by supplier and country.
  • Isoket (isosorbide dinitrate) is used to prevent and relieve angina pectoris by dilating veins and coronary arteries, reducing cardiac preload and myocardial oxygen demand; it is a nitrate vasodilator that releases nitric oxide‑mediated vasodilation.
  • Usual doses: for prevention 5–20 mg two to three times daily (immediate‑release, titrate to effect); for acute angina sublingual 2.5–5 mg at onset, repeat as needed under medical advice.
  • Administration forms include sublingual tablets (2.5 mg, 5 mg, 10 mg), oral immediate‑release tablets (5–40 mg) and extended‑release oral tablets (20–40 mg); taken sublingually for acute attacks or swallowed for chronic prophylaxis.
  • Onset: sublingual effect usually begins within 1–5 minutes; oral immediate‑release typically starts within 15–30 minutes.
  • Duration of action: sublingual effects commonly last about 30–60 minutes; oral immediate‑release effects typically 4–6 hours, while extended‑release formulations may act longer; a nitrate‑free interval of 12–14 hours is recommended to reduce tolerance.
  • Avoid or minimise alcohol while taking isoket, as alcohol can amplify blood‑pressure lowering effects and increase dizziness and fainting risk.
  • The most common side effect is headache.
  • Would you like to try “isoket” without a prescription?
Trackable delivery 5-9 days
Payment method Visa, Mastercard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Isoket

Basic Isoket Information

  • INN (International Nonproprietary Name): Isosorbide dinitrate.
  • Brand Names Available In United Kingdom: Carvasin, Flindix, Isoket, Isorbid, Nitrosorbide, Sorbidilat (regional generics and brand variants reported in EU markets).
  • ATC Code: C01DA08 — vasodilators used in cardiac diseases, specifically nitrates.
  • Forms & Dosages: Sublingual tablets 2.5 mg, 5 mg, 10 mg; Oral immediate‑release tablets 5 mg, 10 mg, 20 mg, 30 mg, 40 mg; Extended‑release tablets commonly 20 mg and 40 mg.
  • Manufacturers In United Kingdom: not specified.
  • Registration Status In United Kingdom: not specified.
  • OTC / Rx Classification: Prescription Only (Rx) in all regulated markets.

Important Instructions & Daily-Life Warnings

Are you carrying the right information in your wallet and medicines card?

  • Follow your NHS prescription and pharmacist advice; isosorbide dinitrate is prescription‑only and should only be used under a prescriber’s directions.
  • Do not buy isosorbide dinitrate from unregulated international sites; check MHRA guidance and only use licensed UK suppliers or NHS pharmacies.
  • Always tell your GP, cardiologist and pharmacist if you take or might take PDE5 inhibitors such as sildenafil or tadalafil — the combination is contra‑indicated and can cause severe hypotension.
  • Carry a brief GP or cardiologist letter if you are taking nitrates and a wallet alert card noting the contraindication with PDE5 inhibitors for emergency staff.
  • Store medicines at room temperature (around 25°C), protect them from light and humidity and keep them in the original light‑resistant container supplied by the pharmacy.
  • If you feel faint after a dose, sit or lie down immediately; severe light‑headedness or fainting requires emergency care and assessment.
  • Recognise overdose signs — severe hypotension, rapid heartbeat and intense headache — and go to A&E if these occur.
  • Plan a daily nitrate‑free period of about 12–14 hours to prevent tolerance; for many people this means avoiding the evening dose until the next morning.
  • Preferable format: keep a one‑page checklist on your medicines card and a wallet alert card for interactions and emergency contacts.

Everyday Use & Best Practices

Worried about fitting nitrate tablets into a busy UK day?

Isosorbide dinitrate is commonly taken two to three times daily for chronic angina prevention, with immediate‑release adult doses typically starting at 5–20 mg two to three times a day.

A practical UK routine is to take the first dose after breakfast, a second mid‑afternoon, and the last in the early evening so you get a nitrate‑free interval overnight of about 12–14 hours to reduce tolerance.

If you are elderly or are sensitive to blood‑pressure drops, take doses while sitting or lying down and stand up slowly afterwards.

Food does not strictly prevent dosing, but a heavy, fatty British breakfast or a large evening meal can accentuate post‑prandial hypotension — watch how you feel after meals.

Caffeine from tea or coffee may mask dizziness, while alcohol can increase vasodilation and worsen light‑headedness — avoid alcohol close to dosing times.

Keep a dosing diary to bring to NHS reviews and cardiology follow‑ups so clinicians can see timing, symptom control and side‑effects.

  • Daily Schedule Example: After breakfast (07:30–09:00) — mid‑afternoon (14:00–16:00) — early evening (18:00–19:30) to allow a nitrate‑free night.
  • Elderly/Fragile Patients: Start at the lower end of 5 mg and avoid standing quickly after a dose.
Regimen Option When To Take Notes
Twice Daily After breakfast and mid‑afternoon May suit those needing fewer doses; keep 12–14 hour nitrate‑free period overnight.
Three Times Daily Breakfast, mid‑afternoon, early evening Useful for stable symptom control; ensure last dose allows nitrate‑free night.
Sublingual For Acute Attacks At onset of chest discomfort 2.5–5 mg under the tongue for rapid relief; keep for emergency use, not regular replacement.

Safety Priorities

Worried whether nitrates are safe for you?

Who Should Avoid It (MHRA Warnings)

Do not take isosorbide dinitrate if you have a known allergy to nitrates or if you are using a PDE5 inhibitor such as sildenafil or tadalafil because of the risk of life‑threatening low blood pressure.

Avoid nitrates in acute circulatory shock, severe anaemia, raised intracranial pressure or after recent head trauma, and where severe hypotension is present.

If you have aortic or mitral stenosis, glaucoma or are significantly volume depleted, your prescriber will weigh risks and consider alternatives or additional monitoring.

The MHRA encourages clinicians and pharmacists to check full medication lists before issuing nitrates and to report serious adverse reactions via the Yellow Card scheme.

Activities To Limit (Driving, Work Safety)

If you experience dizziness, visual disturbance or syncope after a dose do not drive or operate machinery until you are fully symptom‑free.

UK drivers must report any episode of loss of consciousness to the DVLA and discuss fitness to drive with their GP before returning to driving.

If you work in manual occupations such as construction or professional driving, inform occupational health and your employer and avoid safety‑critical tasks while you are establishing your response to treatment.

  • Contraindication Checklist: Known nitrate allergy; concurrent PDE5 inhibitor use; acute shock; severe hypotension; recent head injury — discuss immediately with your prescriber.
  • Employer/Driver Checklist: Record any fainting; notify DVLA if you lose consciousness; get written clearance from GP before resuming driving.

Dosage & Adjustments

Not sure what dose is right and when your dose should change?

General Regimen (NHS Guidance)

Follow the NHS‑issued prescription and cardiology advice for dose and frequency.

Typical adult prevention dosing for immediate‑release tablets is 5–20 mg two to three times daily, titrated according to angina control and orthostatic symptoms.

Sublingual dosing for acute angina attacks is usually 2.5–5 mg under the tongue as needed for relief, with medical oversight for frequent attacks.

Extended‑release formulations such as 20 mg or 40 mg tablets are available and chosen by the clinician based on individual needs and adherence concerns.

Dose titration should be gradual and guided by symptomatic benefit and any orthostatic or symptomatic hypotension.

Special Cases (Elderly, Comorbidities)

Start older patients at the lower end of the dosing range because of increased sensitivity to blood‑pressure drops and risk of falls.

In hepatic or renal impairment no precise formal adjustments are specified but clinicians will often reduce dose or increase monitoring frequency to watch for prolonged effect and hypotension.

Isosorbide dinitrate is not generally recommended for children as paediatric dosing is not established.

Patient Group Typical Starting Dose Monitoring Checks
Adults (Prevention) 5–20 mg two–three times daily (immediate‑release) Blood pressure, symptom diary, orthostatic symptoms
Acute Attack (Sublingual) 2.5–5 mg as needed Relief timing, frequency of attacks, seek review if frequent
Elderly / Frail Start low (e.g., 5 mg) BP checks, fall risk assessment, renal/hepatic monitoring

User Testimonials

What do UK patients say about isosorbide dinitrate in everyday life?

Positive Reports From UK Patients

Many patients report improved exercise tolerance and fewer angina attacks when isosorbide dinitrate is added to other antianginal therapy.

Sublingual tablets are commonly praised for rapid relief of sudden chest discomfort and are carried for emergencies.

Several people note that headaches and flushing are common at first but often settle over a few days as the body adjusts.

Common Challenges (Patient.info, NHS Forums)

Forums on Patient.info and NHS pages often stress the importance of a strict nitrate‑free window to keep the drug effective over weeks and months.

Common problems include troublesome headaches, dizziness on standing, and difficulties timing doses around sleep, work and social life.

Some patients report subtle differences between brands and generics in onset and tolerability, for example between Isoket formulations and other nitrates.

  • Patient Tips: Carry sublingual tablets in their original packaging; keep a symptom diary for GP visits; discuss persistent side‑effects with your pharmacist.
  • Mini Clinic Checklist: Bring dosing diary, record of side‑effects, list of all medicines including OTCs and herbal remedies, and any notes on fainting or falls.

Buying Guide

Where can you get isosorbide dinitrate safely and what will it cost?

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Isosorbide dinitrate is prescription‑only in the UK and is usually supplied via NHS prescriptions dispensed at high‑street pharmacies including Boots, LloydsPharmacy and Superdrug, as well as community NHS contractors and reputable online pharmacies that require a valid prescription.

Generics are commonly stocked under names such as Isoket and other manufacturer labels.

Do not purchase nitrates from unregulated international sites that do not require a prescription; MHRA warnings advise against importing prescription medicines without proper oversight.

In our online pharmacy, isoket is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Price Comparison (NHS Prescription Charge Vs Private)

In England, most people pay the NHS prescription charge per item unless they qualify for an exemption, while prescriptions are free in Scotland, Wales and Northern Ireland.

Private prescription costs and online prices vary by supplier; compare per‑pack prices, tablet strengths and pack sizes (sublingual 2.5/5/10 mg; oral 5–40 mg).

Source Typical Access Price Note
Boots / LloydsPharmacy / Superdrug Collect with NHS or private prescription Subject to NHS prescription charge in England; compare private prices for pack sizes
Community NHS Pharmacy NHS prescription collection and advice Free prescriptions in Scotland, Wales and Northern Ireland; charge applies in England unless exempt
Reputable Online Pharmacies Dispense with valid prescription Check supplier accreditation; avoid unregulated international sellers
  • Quick Safe‑Buying Checklist: Always get a valid prescription; confirm MHRA‑licensed product; keep proof of prescribing for NHS or clinic reviews.

What’s Inside & How It Works

Wondering what the tablets contain and why they ease chest pain?

Ingredients Overview

The active ingredient is isosorbide dinitrate, available as sublingual and oral immediate‑release and extended‑release tablets.

Excipients vary by manufacturer; if you have allergies to lactose, dyes or tablet components check the product leaflet or ask your pharmacist before taking.

Typical strengths include sublingual 2.5, 5 and 10 mg; oral immediate‑release 5–40 mg; and extended‑release 20 and 40 mg tablets.

Mechanism Basics Explained Simply

Isosorbide dinitrate works by releasing nitric oxide in the vessel wall, which relaxes vascular smooth muscle and dilates veins and coronary arteries.

This reduces the heart’s workload and improves blood flow to the heart muscle, which eases angina symptoms during exertion or stress.

Common side‑effects such as headache occur because cerebral vessels also dilate as part of the same mechanism.

  • Active Ingredient: Isosorbide dinitrate.
  • Common Excipients: Vary by brand — consult leaflet for lactose or dye content.
  • Pharmacological Effect: Venodilation and coronary artery dilation via nitric oxide release.

Main Indications

Why will your clinician prescribe isosorbide dinitrate and what else might it be used for?

Approved Uses (MHRA Listing)

The primary approved use is prevention and symptomatic treatment of angina pectoris, with sublingual tablets used for acute attacks.

The drug is classified under ATC code C01DA08 for nitrate vasodilators used in cardiac disease and long‑term regimens are prescribed with nitrate‑free intervals to avoid tolerance.

Off‑Label Uses In UK Clinics

Occasionally clinicians use nitrates for conditions such as oesophageal spasm or as an adjunct for symptom control in severe heart failure, but such use is case‑by‑case under specialist supervision.

Off‑label prescribing should be documented with a clear explanation of risks and benefits discussed with the patient.

Approved Indication Off‑Label Use Notes
Angina Pectoris Prevention and Treatment Oesophageal Spasm (selected cases) Specialist decision and documentation required for off‑label uses.
Sublingual For Acute Attacks Adjunct In Severe Heart Failure Symptoms Used selectively under cardiology guidance.

Interaction Warnings

Worried about foods, drinks or other medicines that could harm you when taking nitrates?

Food Interactions (Alcohol, Tea/Coffee)

Alcohol potentiates vasodilation and can increase dizziness and fainting risk, so avoid drinking around dosing times.

Caffeine from tea and coffee may mask feelings of dizziness but does not cause a dangerous pharmacological interaction; still monitor for post‑dose light‑headedness.

Drug Conflicts (MHRA Yellow Card Reports)

The major and potentially life‑threatening interaction is with PDE5 inhibitors such as sildenafil and tadalafil; never combine these with nitrates.

Other antihypertensives, diuretics and some psychotropic drugs may amplify the blood‑pressure lowering effects of nitrates.

Report severe reactions such as syncope or sudden severe headache to the MHRA Yellow Card scheme so safety surveillance can track events.

  • Tell your pharmacist about: all prescription medicines, PDE5 inhibitors, antidepressants, antihypertensives, diuretics and any herbal products or OTC painkillers.
Medicine Interaction Risk Action
Sildenafil / Tadalafil Severe hypotension Contra‑indicated — never combine; seek alternative therapy.
Antihypertensives / Diuretics Potentiation of low blood pressure Monitor BP and adjust doses as needed.

Latest Evidence & Insights

What does recent UK and EU research say about long‑term nitrate use?

Key UK & EU Studies 2022–2025

Recent analyses through to 2025 focused on long‑term nitrate strategies, tolerability and adherence, and comparisons between isosorbide dinitrate, isosorbide mononitrate and nicorandil.

Evidence continues to emphasise the importance of a nitrate‑free interval of 12–14 hours to preserve efficacy and reduce tolerance during chronic use.

Some studies suggest switching to once‑daily isosorbide mononitrate may help patients who struggle with multiple daily immediate‑release doses and adherence.

Safety surveillance remains consistent: headaches and hypotension are common adverse events but no novel major safety signals have emerged in recent UK/EU monitoring.

  • Study Conclusions: Maintain nitrate‑free intervals; consider once‑daily alternatives where adherence is the issue; monitor for hypotension and headaches.

One‑line Summary For Patients: Nitrates work well for many people with angina if taken on the right schedule and with careful monitoring for side‑effects.

Alternative Choices

Not tolerating nitrates or want a simpler dosing plan?

NHS Prescribing Alternatives With Pros/Cons Checklist

Common NHS alternatives include isosorbide mononitrate, glyceryl trinitrate (nitroglycerin) and nicorandil, each with distinct pros and cons.

Alternative Pros Cons
Isosorbide Mononitrate Once‑daily dosing, simpler adherence Still a nitrate — similar side‑effect profile; clinical choice needed
Glyceryl Trinitrate (Sublingual) Rapid onset for acute attacks Short duration; not for continuous control
Nicorandil Useful where nitrates not tolerated; different mode of action Different side‑effects; specialist prescribing considerations
  • Decision Checklist: Consider symptom pattern, blood pressure tolerance, comorbidities, interaction risk and patient preference before switching.

Regulation Snapshot

How is isosorbide dinitrate regulated and what should prescribers and pharmacists record?

MHRA Approval & NHS Prescribing Framework

Isosorbide dinitrate is prescription‑only across regulated markets and UK prescribing follows MHRA‑approved product information together with local NHS formularies.

Various generics and historic brand names circulate; clinicians and pharmacists rely on current MHRA summaries and local trust formularies when selecting products.

Pharmacists must verify regulatory status before supplying imports or atypical formulations and should counsel patients on interactions and side‑effects.

Suspected adverse reactions should be reported via the MHRA Yellow Card scheme and prescribers should document indication, dose and rationale in clinical records.

Step Action
Prescribing Use MHRA product information and local formularies; document indication and dose.
Dispensing Check interactions, counsel on nitrate‑free interval and storage; supply in original container.
Monitoring Record adverse effects, report Yellow Card submissions, liaise with prescriber for dose changes.

FAQ Section

Have quick questions about taking nitrates? Here are the answers most patients ask.

  • Can I drive while taking isosorbide dinitrate? Not if you experience dizziness or fainting after dosing; report any loss of consciousness to the DVLA and consult your GP before returning to driving.
  • What if I miss a dose? Take it as soon as you remember unless it is near your next scheduled dose — do not double up.
  • Can I drink alcohol or take Viagra? Avoid alcohol around dosing; never take PDE5 inhibitors with nitrates as this combination is contra‑indicated.
  • How should I store my tablets? Store at room temperature (around 25°C), protected from light and humidity in the original container supplied by the pharmacy.
  • What To Tell Your Pharmacist: All current medicines including OTCs and herbal remedies, any episodes of fainting, pregnancy or breastfeeding status, and any known allergies.

Guidelines For Proper Use

What should a UK pharmacist tell a patient starting isosorbide dinitrate?

UK Pharmacist Counselling Style

Use a brief, patient‑centred checklist: confirm the indication (angina), review all medicines especially PDE5 inhibitors, advise on expected side‑effects like headache and dizziness, explain the nitrate‑free interval of 12–14 hours and agree an emergency plan for syncope or severe hypotension.

Provide written information, encourage Yellow Card reporting for serious adverse events and offer adherence aids such as pill boxes or reminder cards.

Community pharmacists in chains such as Boots or LloydsPharmacy often liaise with GPs to discuss dose review if side‑effects or adherence problems arise.

NHS Patient Support Advice

Advise patients to keep an angina action card with dose, GP or cardiologist contact details and allergy list, and to use a symptom diary for clinic reviews.

Ask about prescription charge exemption status and offer support or signposting to NHS services for cost queries.

  • Printable Counselling Checklist For Pharmacists: Confirm indication; list medicines; warn about PDE5 inhibitors; teach how to take sublingual dose; advise on nitrate‑free interval and storage; plan emergency actions.
  • Patient Wallet Card Template: Medicine name, dose, timing, prescriber contact, emergency instructions and drug interactions (notably PDE5 inhibitors).

Delivery Across United Kingdom

City Region Delivery time
London Greater London 5–7 days
Manchester Greater Manchester 5–7 days
Birmingham West Midlands 5–7 days
Leeds West Yorkshire 5–7 days
Glasgow Scotland 5–7 days
Edinburgh Scotland 5–7 days
Liverpool Merseyside 5–7 days
Bristol South West England 5–7 days
Newcastle Upon Tyne North East England 5–9 days
Sheffield South Yorkshire 5–9 days
Nottingham Nottinghamshire 5–9 days
Cardiff Wales 5–7 days
Belfast Northern Ireland 5–9 days
Plymouth South West England 5–9 days